Vmbook Online ordering

Quintiles Transnational Holdings Inc

Quintiles Transnational Holdings Inc., which was later known as Quintiles IMS Holdings Inc., was a public company based in the United States that operated in the healthcare industry. The company was a provider of biopharmaceutical development and commercial outsourcing services.

Quintiles was founded in 1982 and went public in 1994. The company's stock was listed on the New York Stock Exchange (NYSE) under the ticker symbol "Q."

Quintiles provided a range of services to the biopharmaceutical industry, including clinical development, commercialization, and consulting services. The company's clients included pharmaceutical, biotechnology, and medical device companies, as well as government agencies and academic institutions.

In 2016, Quintiles merged with IMS Health to form Quintiles IMS Holdings Inc., creating a leading global provider of integrated information and technology-enabled healthcare services. The merger was intended to enhance the combined company's ability to provide end-to-end solutions to its clients in the healthcare industry.

However, in 2017, the company announced that it would be changing its name to IQVIA Holdings Inc. to reflect the company's broader capabilities and focus on using data, technology, and expertise to help its clients make better healthcare decisions.

Today, IQVIA is a publicly traded company listed on the NYSE under the ticker symbol "IQV." The company has a market capitalization of several billion dollars and operates in over 100 countries around the world.